LB Pharmaceuticals Inc (NASDAQ:LBRX) IPO will take place September, 11 on the NASDAQ exchange under the ticker LBRX.

The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on March 10, 2026.

See also: Benzinga IPO Calendar

About LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.